4 minute read
Feb. 25, 2023

The First Approved Oral ER Degrader

elacestrant

oral, non-steroidal SERD/SERM approved for ER+, HER2-, mESR1 adv./metastatic BC degrades ERɑ in dose-dependent manner FDA approval, January 27, 2023 Eisai, Tokyo, JP (Stemline/Menarini)

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in